Glaucoma Drug Gets New Indication for Skimpy Eyelashes

December 30, 2008 · Posted in Daily Health News · Comment 

IRVINE, Calif. (MedPage Today) — The FDA has approved the glaucoma drug bimatoprost for treatment of eyelash hypotrichosis — lashes that are not long, thick, or dark enough — the drug’s maker announced here.

See the article here:
Glaucoma Drug Gets New Indication for Skimpy Eyelashes

FDA Approves Allergan’s Drug for Longer Eyelashes

December 29, 2008 · Posted in Daily Health News · Comment 

Allergan Inc, maker of Botox, said on Friday that the U.S. Food and Drug Administration has approved its eyelash-thickening drug Latisse

See the rest here:
FDA Approves Allergan’s Drug for Longer Eyelashes

Allergan Announces U.S. Food and Drug Administration (FDA) Approval of Latisse — First and Only Treatment Approved by the FDA for Hypotrichosis of…

December 29, 2008 · Posted in Daily Health News · Comment 

IRVINE, Calif.–(BUSINESS WIRE)–Dec 26, 2008 – Allergan, Inc. today announced the U.S. Food and Drug Administration (FDA) has approved Latisse (bimatoprost ophthalmic solution) 0.03% as a novel treatment for hypotrichosis of the eyelashes.

Read more:
Allergan Announces U.S. Food and Drug Administration (FDA) Approval of Latisse — First and Only Treatment Approved by the FDA for Hypotrichosis of…

A case of trichomegaly of the eyelashes and facial hypertrichosis induced by erlotinib (Tarceva®)

December 27, 2008 · Posted in Daily Health News · Comment 

(Source: International Journal of Dermatology)

Original post:
A case of trichomegaly of the eyelashes and facial hypertrichosis induced by erlotinib (Tarceva®)

FDA OKs Latisse For Hypotrichosis of Eyelashes Treatment

December 27, 2008 · Posted in Daily Health News · Comment 

New prescription drug Latisse increases the length, thickness and darkness of eyelashes. (Source: Huliq Health News)

Read more from the original source:
FDA OKs Latisse For Hypotrichosis of Eyelashes Treatment

Allergan Eyelash Enhancer Approved

December 27, 2008 · Posted in Daily Health News · Comment 

Allergan received FDA approval to market Latisse, a beauty treatment that increases the length, thickness and darkness of eyelashes by using a drug the company developed to treat glaucoma. (Source: WSJ.com: Health)

Read the original post:
Allergan Eyelash Enhancer Approved

LATISSEâ„¢ – New Prescription Product Increases Length, Thickness And Darkness Of Eyelashes

December 27, 2008 · Posted in Daily Health News · Comment 

Allergan, Inc. (NYSE: AGN) today announced the U.S. Food and Drug Administration (FDA) has approved LATISSEâ„¢ (bimatoprost ophthalmic solution) 0.03% as a novel treatment for hypotrichosis of the eyelashes.

Follow this link:
LATISSEâ„¢ – New Prescription Product Increases Length, Thickness And Darkness Of Eyelashes

Glaucoma Drug Doubles As Eyelash Enhancer

December 8, 2008 · Posted in Daily Health News · Comment 

A panel of government experts said Friday a glaucoma drug from Allergan appears to be a safe and effective way to make eyelashes longer and fuller. (Source: Health News: CBSNews.com)

Go here to see the original:
Glaucoma Drug Doubles As Eyelash Enhancer

FDA Advisory Committee Unanimously Recommends Approval of Latisse (Bimatoprost Solution 0.03%) as a Treatment for Hypotrichosis of Eyelashes

December 8, 2008 · Posted in Daily Health News · Comment 

IRVINE, Calif.–(BUSINESS WIRE)–Dec 5, 2008 – Allergan, Inc. today announced the U.S. Food and Drug Administration (FDA) Dermatologic and Ophthalmic Drugs Advisory Committee (DODAC) voted unanimously (9-0) to recommend that the FDA approve Latisse…

Read more:
FDA Advisory Committee Unanimously Recommends Approval of Latisse (Bimatoprost Solution 0.03%) as a Treatment for Hypotrichosis of Eyelashes

Hypotrichosis Of Eyelashes – FDA Advisory Committee Unanimously Recommends Approval Of LATISSEâ„¢ (Bimatoprost Solution 0.03%)

December 7, 2008 · Posted in Daily Health News · Comment 

Allergan, Inc. (NYSE: AGN) today announced the U.S. Food and Drug Administration (FDA) Dermatologic and Ophthalmic Drugs Advisory Committee (DODAC) voted unanimously (9-0) to recommend that the FDA approve LATISSEâ„¢ (bimatoprost solution 0.03%) as a treatment for hypotrichosis (or reduced amount of hair) of the eyelashes

Follow this link:
Hypotrichosis Of Eyelashes – FDA Advisory Committee Unanimously Recommends Approval Of LATISSEâ„¢ (Bimatoprost Solution 0.03%)

FDA OKs Drug for Enhancing Eyelashes

December 5, 2008 · Posted in Daily Health News · Comment 

Allergan’s glaucoma solution may see more lucrative use on the cosmetic scene. (Source: ABC News: Health) MedWorm Message: Register for MedMatcha, MedWorm’s medical advertising network , and receive $5 free advertising.

View post:
FDA OKs Drug for Enhancing Eyelashes

Allergan eyelash drug wins U.S. panel backing

December 5, 2008 · Posted in Daily Health News · Comment 

ROCKVILLE, Maryland (Reuters) – An Allergan Inc glaucoma drug is safe and effective enough for U.S.

See the original post:
Allergan eyelash drug wins U.S. panel backing

Next Page »